Hoerter Steven L. 4
4 · Oric Pharmaceuticals, Inc. · Filed Jan 6, 2026
Insider Transaction Report
Form 4
Hoerter Steven L.
Director
Transactions
- Award
Stock Option (right to buy)
2026-01-02+40,000→ 40,000 totalExercise: $8.17Exp: 2036-01-01→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]1/12th of the shares subject to the option shall vest on each one month anniversary of January 2, 2026.